| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 02/07/2006 | US6995172 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/07/2006 | US6995170 formed by reacting 7-halogeno-8-cyano-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid with (1S,6S)-2,8-diazabicyclo[4.3.0]nonane in presence of base/diluent; for use as antibacterial agent |
| 02/07/2006 | US6995168 such as 5-[8-(3-dimethylcarbamoyl-3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-pentanoic acid; side effect reduction; for stimulating opioid receptors |
| 02/07/2006 | US6995167 Arylkylamine spirofuropyridines useful in therapy |
| 02/07/2006 | US6995163 having an excellent corticotrophin-releasing-factor receptor antagonistic activity; for treating or preventing depression, nerve system disorders, schizophrenia, peptic ulcer, irritable bowel syndrome |
| 02/07/2006 | US6995162 Substituted alkylamine derivatives and methods of use |
| 02/07/2006 | US6995148 Hypotensive agents, vasodilation, antiischemic agents, cardiovascular disorders |
| 02/07/2006 | US6994843 Delivery of stimulants through an inhalation route |
| 02/07/2006 | CA2360308C Glucocorticoid receptor modulators |
| 02/07/2006 | CA2143853C 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity |
| 02/02/2006 | WO2006012374A1 Substituted aryl-amine derivatives and methods of use |
| 02/02/2006 | WO2006011670A1 PYRROLO[2,3-c]PYRIDINE COMPOUND, PROCESS FOR PRODUCING THE SAME, AND USE |
| 02/02/2006 | WO2006010811A1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
| 02/02/2006 | WO2006010423A2 Azaindole inhibitors of mtp and apob |
| 02/02/2006 | WO2005118541A3 Heterocyclic compounds and their use as aldosterone synthase inhibitors |
| 02/02/2006 | WO2005118540A3 Bicyclic, nitrogen-containing heterocycles as aromatase inhibitors |
| 02/02/2006 | WO2005115392A3 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 02/02/2006 | WO2005103032A3 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds |
| 02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
| 02/02/2006 | US20060025588 Directly hydrogenating a heteroaryl alpha-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst; for example, the heteroaryl acetamide is zolpidem and the heteroaryl alpha-hydroxyacetamide is alpha-hydroxyzolpidem |
| 02/02/2006 | US20060025454 Prenylation inhibitors and methods of their synthesis and use |
| 02/02/2006 | US20060025451 Novel pyrazole compounds as transforming growth factor (TGF) inhibitors |
| 02/02/2006 | US20060025435 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025425 Benzimidazole and pyridylimidazole derivatives |
| 02/02/2006 | US20060025417 Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives |
| 02/02/2006 | US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060024523 Organic electroluminescence device |
| 02/02/2006 | US20060024330 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
| 02/02/2006 | CA2575223A1 Azaindole inhibitors of mtp and apob |
| 02/02/2006 | CA2573920A1 Histamine-3 receptor antagonists |
| 02/02/2006 | CA2572121A1 Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
| 02/01/2006 | EP1621540A1 Nitrogen-containing heterocyclic compounds and use thereof |
| 02/01/2006 | EP1620525A1 Organic electroluminescent device and platinum compound |
| 02/01/2006 | EP1620445A2 Method and compositions for identifying anti-hiv therapeutic compounds |
| 02/01/2006 | EP1620440A1 Synthesis of substituted heterocyclic compounds |
| 02/01/2006 | EP1620435A1 IMADAZOPYRIDINE COMPOUNDS HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY AND 5-HT sb 3 /sb RECEPTOR ANTAGONISTIC ACTIVITY |
| 02/01/2006 | EP1620420A2 Substituted carboxylic acids |
| 02/01/2006 | EP1620105A1 (6-(phenoxy)-pyrido[3,4-d]pyrimidin-2-yl)-amine derivatives as p38 kinase inhibitors for the treatment of inflammatory conditions such as rheumatoid arthritis |
| 02/01/2006 | EP1620095A2 Inhibitors of akt activity |
| 02/01/2006 | EP1620091A2 Inhibitors of glutaminyl cyclase |
| 02/01/2006 | EP1620082A2 Medical use of inhibitors of glutaminyl and glutamate cyclases |
| 02/01/2006 | EP1619948A1 Sustituted imidazolopyrazine and triazolopyrazine derivatives: gabaa receptor ligands |
| 02/01/2006 | EP1436293B1 Polycyclic compounds having anti-tumor activity |
| 02/01/2006 | EP1425281B1 Tricyclic CRF receptor antagonists |
| 02/01/2006 | EP1311625B1 Functionalized perylene tetracarboxylic acid diimides |
| 02/01/2006 | EP1119563B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 02/01/2006 | CN1729194A Fungicides based on nitrogen-containing heterocycles |
| 02/01/2006 | CN1729191A Pyrazoloquinolines with immunomodulating activity |
| 02/01/2006 | CN1729190A Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics |
| 02/01/2006 | CN1729189A Pyridino [2, 3-D] pyrimidine derivatives as selective KDR and FGFR inhibitors |
| 02/01/2006 | CN1729188A Synthesis of heteroaryl acetamides |
| 02/01/2006 | CN1239631C Acid pigment dispersants and pigment preparations |
| 02/01/2006 | CN1239503C Liquid crystalline-3, 4:9, 10-perylenetetracarboxylic acid diimides |
| 02/01/2006 | CN1239497C Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 02/01/2006 | CN1239496C Respiratory syncytial virus replication inhibitors |
| 01/31/2006 | US6992192 preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase used for prophylaxis of erectile dysfunction and cardiovascular disorders |
| 01/31/2006 | US6992188 Nitrogen compounds such as 2,5,6-trimethyl-7-(1-propylbutyl)-4-(2,4,6-trimethylphenoxy)-7H-pyrrolo[2,3-d]pyrimidine, used as Corticotropin-releasing factor (CRF) antagonists |
| 01/31/2006 | US6992102 Bicyclic modulators of androgen receptor function |
| 01/31/2006 | US6992089 Anticancer agents; bactericides, fungicides |
| 01/31/2006 | US6992088 Tetracyclic or pentacyclic cytotoxic agents, enzyme inhibitors, anticarcinogenic agents, bactericides, fungicides |
| 01/31/2006 | US6992086 Antagonists of MCP-1 function and methods of use thereof |
| 01/31/2006 | US6992085 Octahydro-2H-pyrido[1,2-a]pyrazine compounds |
| 01/31/2006 | US6992080 For therapy of cancer, inflammation, arthritis, viral diseases, neurodegenerative diseases such as Alzheimer's disease, cardiovascular diseases, and fungal diseases |
| 01/31/2006 | US6992077 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 01/31/2006 | US6991858 Electrolytic cells; stability, purity |
| 01/31/2006 | CA2224635C Pyridine derivatives, process for preparing the same, and intermediate therefor |
| 01/31/2006 | CA2208839C Quinuclidine derivatives and medicinal composition thereof |
| 01/26/2006 | WO2006009789A2 Aryl-substituted piperazine derivatives |
| 01/26/2006 | WO2006008636A2 Processes for the preparation of zolpidem and its hemitartrate |
| 01/26/2006 | WO2006008493A1 Synthesis of polyhydroxylated alkaloids |
| 01/26/2006 | WO2006008303A1 Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof |
| 01/26/2006 | WO2006008302A2 Improved process for the manufacture of mirtazapine |
| 01/26/2006 | WO2005110982A3 Substituted 1-benzyl-4-substituted piperazine analogues |
| 01/26/2006 | WO2005097788A3 Sulfonamides and uses thereof |
| 01/26/2006 | WO2005079868A3 Crf receptor antagonists, their preparations, their pharmaceutical composition and their uses |
| 01/26/2006 | WO2004096798A3 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists |
| 01/26/2006 | WO2001085170A9 Peptide deformylase inhibitors |
| 01/26/2006 | US20060020134 Selective and specific preparation of discrete peg compounds |
| 01/26/2006 | US20060020132 high binding efficiencies between D3 and D2 dopaminergic receptor subtypes; drug abuse, drug dependence |
| 01/26/2006 | US20060020012 Pyrazole derivatives |
| 01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 01/26/2006 | US20060019981 Reacting ethyl-1-(3-acetylenylphenyl)-1,4-dihydro(1,8)naphthyridin-4-one-3-carboxylate with 3- bromopyridine in palladium catalyst, phosphine ligand and amine base, and them amidating the ester with cyclopropylamine; one pot process |
| 01/26/2006 | US20060019977 Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient |
| 01/26/2006 | US20060019960 Antitumoral analogs of ET-743 |
| 01/26/2006 | CA2574625A1 Process for the preparation of (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionamide and (2r, 3r)-2-hydroxy-3-amino-3-aryl-propionic acid alkyl ester |
| 01/26/2006 | CA2574204A1 Fused pyrimidones useful in the treatment and the prevention of cancer |
| 01/26/2006 | CA2572831A1 Improved process for the manufacture of mirtazapine |
| 01/26/2006 | CA2572047A1 Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
| 01/26/2006 | CA2570968A1 Gonadotropin releasing hormone receptor antagonists |
| 01/26/2006 | CA2570817A1 Azaindoles modulating c-kit activity and uses therefor |
| 01/26/2006 | CA2567604A1 Aryl-substituted piperazine derivatives |
| 01/25/2006 | EP1619194A2 Triazaspiro[5.5]undecane derivatives and pharmaceutical composition comprising the same as active ingredient |
| 01/25/2006 | EP1619193A1 Spiropiperidine compound and medicinal use thereof |
| 01/25/2006 | EP1619192A2 Aryl fused azapolycyclic compounds |
| 01/25/2006 | EP1618107A1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists |
| 01/25/2006 | EP1617856A2 Somatostatin-dopamine chimeric analogs |
| 01/25/2006 | EP1617841A1 Amino cyclobutylamide modulators of chemokine receptor activity |